Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Clinical trial NCT04949009 · UNKNOWN

Trial details

NCT number: NCT04949009
Sponsor: Shandong University
Status: UNKNOWN
Study type: OBSERVATIONAL

Primary Immune Thrombocytopenia

Start date: 2021-03-01
Primary completion: 2021-10-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.